Table 3 Demographic information of datasets T1.1-T1.4, and the merged dataset.

From: Evaluating HbA1c-to-average glucose conversion with patient-specific kinetic models for diverse populations

 

T1.2. - DirectNet - CGM in Young Children

T1.3. - DirectNet - Metabolic Control

T1.4. - RT-CGM

Merged Dataset

All

Used Data

All

Used

All

Used Data

Used

Participants

T1D

T1D

T1D

T1D

T1D

T1D

T1D, At-risk/pre-diabetes or T2D

n

146

30

71

19

451

33

247

Age - Mean (SD)

7.2 ± 1.8

6.9 ± 2

12.9 ± 5.6

13.3 ± 6.4

25 ± 15.8

21.2 ± 11.8

39.6 ± 21.6

BMI - Mean (SD)

17.4 ± 2.2

17.3 ± 1.9

18.4 ± 3.5

18.3 ± 3.4

23.5 ± 4.4

23.1 ± 4.7

26 ± 6.4

Gender

Female

79 (54.1%)

17 (56.7%)

25 (35.2%)

8 (42.1%)

248 (55%)

21 (63.6%)

150 (60.7%)

Male

67 (45.9%)

13 (43.3%)

46 (64.8%)

11 (57.9%)

203 (45%)

12 (36.4%)

97 (39.3%)

Race/Ethnicity

Non-Hispanic White

112 (76.7%)

23 (76.6%)

63 (88.7%)

19 (100%)

417 (92.6%)

30 (90.9%)

135 (54.7%)

Hispanic or Latino

14 (9.6%)

2 (6.6%)

3 (4.2%)

0

15 (3.3%)

1 (3.0%)

102 (41.3%)

Black/African American

6 (4.1%)

1 (3.3%)

1 (1.4%)

0

7 (1.6%)

1 (3.0%)

4 (1.6%)

Asian

4 (2.7%)

1 (3.3%)

0

0

2 (0.4%)

0

1 (0.4%)

Other/ Unknown/More than one race

10 (6.8%)

3 (10%)

4 (5.6%)

0

10 (2.2%)

1 (3.0%)

5 (2%)

Laboratory HbA1c

HbA1c < 5.7%

0

0

0

0

6 (1.3%)**

0

40 (16.2%)

5.7%≤ HbA1c ≤ 6.4%

0

0

1 (1.4%)

0

47 (10.5%)

5 (15.2%)

47 (19%)

HbA1c > 6.4%

146 (100%)

30 (100%)

69 (98.6%)*

19 (100%)

396 (88.2%)

28 (84.8%)

160 (64.8%)

Arm/Group

Control

72 (49.3%)

6 (20%)

50 (70.4%)

0

219 (48.6%)

0

NA

Active

74 (50.7%)

24 (80%)

21 (29.6%)

19 (100%)

232 (51.4%)

33 (100%)

NA

Data Segments

CGM Length

Phase 1: 26 weeks

Phase 2: 26 weeks

2 segments > 45 days

up to 2 years

∽9 months of consecutive data

Phase 1: 26 weeks

Phase 2: 26 weeks

3 segments > 45 days

2 segments > 45 days

HbA1c

NA

t1 (equal to t2), and t3

NA

t1, t2, tP3

NA

t1, t2, t3

t1 (equal to t2), and t3

NCT

NCT00760526

NCT00891995

NCT00406133

-

  1. * One participant had no Baseline HbA1c measurement.
  2. ** 2 participants with missing HbA1c measurements at Randomization.